Tag Archives: Department of Health and Human Services

Public Policy Briefing – July 21, 2020

The US Congress has returned to Washington, DC, and bipartisan negotiations to produce the next significant federal coronavirus response legislation have officially begun. Treasury Secretary Steven Mnuchin and White House Chief of Staff Mark Meadows, representing President Donald Trump, are scheduled to meet this afternoon on Capitol Hill with House Speaker Nancy Pelosi (D-CA) and … Continue Reading

Department of Justice Lacks Capacity to Pursue Fraud-related CARES Act Cases

In an article published in Bloomberg Law, we observed that despite Congress’s determination to hold recipients of CARES Act funds accountable, there is likely to be a significant gap between the expected oversight activity, and the capacity of the Department of Justice to, where merited, follow up with criminal prosecution or civil action on fraud … Continue Reading

Transatlantic Trade: US and European Trade Talk Update – June 19, 2020

America and European countries remain focused on securing a COVID-19 vaccine to prevent resurgences of the virus, with the European Commission unveiling a strategy this week to accelerate its coordinated efforts.  At a North Atlantic Treaty Organization (NATO) Defense Ministerial this week, partners focused on COVID-19 and other topics, including the US’ announcement to lower … Continue Reading

COVID-19: US Developments – Implementation and Oversight of CARES Act – May 29, 2020

The stay-at-home order in the nation’s capital has been lifted, while the debate continues in the United States Congress about the scope, timing and focus of the next major bipartisan federal COVID-19 response legislation. Stymied in their efforts to force quick congressional approval of another massive package, Washington Democrats are keeping busy by passing targeted … Continue Reading

FDA User Fee Reauthorization Moves to Full Committee; HHS Further Delays Bundled Payment Models and Changes to 340B Drug Discount Program

Legislative Activity FDA User Fee Reauthorization Moves to Full Committee While passing health reform through Congress has been a struggle, the Food and Drug Administration (FDA) user fee legislation has quickly moved through the regular order process in a bipartisan fashion. S. 934/H.R. 2430, Food and Drug Administration Reauthorization Act of 2017 (FDARA), renews FDA’s … Continue Reading

Gottlieb Confirmation Hearing Set for April 5; CMS Issues Final Rule on Medicaid DSH Payments; Home Health CoPs Delayed; MedPAC Meetings This Week

Legislative Activity Gottlieb Confirmation Hearing Set for April 5 On Wednesday, April 5, the Senate Committee on Health, Education, Labor, and Pensions (HELP) will hold a confirmation hearing for Dr. Scott Gottlieb, President Trump’s nominee for Commissioner of the U.S. Food and Drug Administration (FDA). Dr. Gottlieb held a number of senior positions at the … Continue Reading

Price Finance Confirmation Hearing Set for Tuesday; House to Consider Pro-Life Legislation; President Trump Issues Executive Order on ACA

Legislative Activity Price Finance Confirmation Hearing Set for Tuesday Last week, Rep. Tom Price (R-GA) visited the Senate Committee on Health, Education, Labor, and Pensions (HELP) for the first of two Senate confirmation hearings that resulted in the longest HELP confirmation hearing in over twenty years. The HELP hearing was heated, partisan, and merely a … Continue Reading

Senate Prepares for Vote-a-Rama; Four Bipartisan Health Bills Scheduled for House Floor; HRSA Releases Final Rule on 340B Drug Pricing Program; CMS Extends Temporary Moratoria; MedPAC Meeting This Week

Legislative Activity Senate Prepares for Vote-a-Rama This week, the Senate begins 50 hours of debate on the budget resolution, moving towards the repeal of the Affordable Care Act (ACA) through the budget reconciliation process. While Republicans make final policy decisions on the language and continue to discuss their repeal and replace strategy, Democrats are working … Continue Reading

House to Consider Bipartisan Public Health Legislation; Ways and Means Committee to Hold Hearing on Health Care Fraud; SAMHSA Final Rule on MAT for Opioid Use Disorders Reporting Requirements

Legislative Activity House to Consider Bipartisan Public Health Legislation This week, House Majority Leader Kevin McCarthy announced the consideration of two additional pieces of bipartisan health legislation. H.R. 1877, the Mental Health First Aid Act of 2016, introduced by Rep. Lynn Jenkins (R-KS), amends the Public Health Service Act to require the Substance Abuse and … Continue Reading

House Committee on Energy and Commerce to Mark Up Health Legislation; Potential Senate Vote on Obamacare Repeal This Week; House Committee on the Judiciary Announces Hearings on Competition in the Health Care Marketplace; Medicare Trustees Release Annual Report

Legislative Activity House Committee on Energy and Commerce to Mark Up Health Legislation The House Committee on Energy and Commerce has announced that it will hold a markup on Tuesday, July 28. Several health bills are on the agenda: H.R. 1344, the Early Hearing Detection and Intervention Act of 2015, which reauthorizes a program for … Continue Reading

SCOTUS Decision on ACA Subsidies Expected Any Day; IPAB Repeal Hits House Floor; Appropriations Committees Consider Health Bills; 340B Proposed Rule Released

SCOTUS Watch The Supreme Court is expected to issue its opinion in King v. Burwell by the end of the month, though it is unclear when the decision will be handed down. Currently, the Supreme Court has scheduled non-argument days for June 22 and 29, with a conference day scheduled for June 25. The issue … Continue Reading